| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |